Navigation Links
ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
Date:3/27/2013

FORT WASHINGTON, Pa. and TOKYO, March 27, 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services Inc. ("RPS"), a leading global contract research organization (CRO), and Asklep Inc. ("Asklep"), one of Japan's largest CROs, today announced the creation of a Joint Venture Company (JVC) to deliver leading-edge R&D outsourcing solutions in Japan to the biopharmaceutical and medical device industries. 

The exclusive RPS-Asklep collaboration will leverage RPS' proprietary structures and global footprint to deliver customized solutions across large, mid-size and small and virtual organizations. A breadth of options ranging from embedded, hybrid, and full-service solutions will be available to clients using best-in-class standard operating procedures, processes and systems.  Alan Morgan , RPS' Chief Operating Officer, will assume the role of Chief Executive Officer (CEO) of the JVC, in addition to his current responsibilities.

Commenting upon the announcement Daniel Perlman , CEO and Founder of RPS said, "By combining RPS' innovative approaches to meeting the industry's needs with Asklep's excellent reputation, significant size, and local infrastructure, RPS will be positioned to meet current and future needs across the biopharmaceutical and medical device industries.  Japan is an important market for clinical development and this JVC brings ownership and accountability with mutual success and long-term stability to the benefit of customers."

Hiroshi Ichikawa , President and CEO of Asklep said, "We are delighted to partner with RPS as it provides very unique solutions ranging from embedded, functional and cross-functional programs to enhanced global full-service solutions. Combining RPS' global solutions and Asklep's localized services, we believe the JVC will address an unmet need in Japan."

About RPS  
ReSearch Pharmaceutical Services (RPS), the market leading global provider of innovative outsourcing Clinical Development Solutions, provides comprehensive Phase I-IV services to meet the evolving needs of the Biopharmaceutical, Medical Device and Diagnostic industries, customized by customer type (large, mid-size, and small).  Built organically, RPS is the fastest growing top 10 global Clinical Research Organization (CRO), with more than 5,000 employees and operations in more than 64 countries with proprietary internal structures.  These structures provide both RPS and its partner's greater development flexibility and growth.  RPS is uniquely positioned to provide the following customized clinical development solutions:

  • Large organizations: RPS provides innovative, Embedded, portfolio-wide clinical development solutions  delivering multi-million dollar cost savings, greater quality and the ability to manage more within their portfolio while retaining strategic control and effectively managing regulatory risk. 
  • Midsize organizations: RPS has leveraged its market leading Embedded Clinical Development Solutions expertise providing an innovative model that enables the efficient internal development of a midsize company's product portfolio with greater control and flexibility, accelerated development timelines and substantially reduced costs.
  • Virtual/Small Organizations: RPS provides a comprehensive project based delivery solution with market leading full service processes and tools.  Our in-house drug development expertise combined with outstanding project management means that our clients achieve superior execution on efficiently designed studies.  RPS recruits in excess of 100,000 patients a year with performance ahead of industry leading benchmarks.

For more information about RPS, visit www.rpsweb.com.

About Asklep   
Asklep, Inc., (www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services including monitoring, data management, biostatistics, and comprehensive CRA training. As a member of the Intage Group (http://www.intage.co.jp/), we provide full support service for drug development through medical research and system solutions.


'/>"/>
SOURCE ReSearch Pharmaceutical Services Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Doing Business in China: Research on Chinese Good Manufacturing Practice Regulations for Medical Devices
2. Quantum Materials Corporation Supplies Tetrapod Quantum Dots to U.S. Government Researchers
3. MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013
4. Family Tree DNAs Genomics Research Center Facilitates Discovery of Extremely Ancient Root to the Human Y Chromosome Phylogenetic Tree
5. RFID-over-Wi-Fi RTLS Temperature Sensing Solution Protects Clinical Research Specimens at Fred Hutchinson Cancer Research Center
6. Texas Research Institutions Conducted Over 8,200 Clinical Trials of Medicines Since 1999
7. Research and Markets Announces The Release of Neuromodulation Market - Forecasts to 2017
8. New Research Indicating Serious Potential Risks To Cancer Patients From Oncology Drug Shortages
9. Millennium Research Group Sponsors Case Competition at Western University for Second Year
10. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
11. Hologics 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
Breaking Medicine News(10 mins):